跳至主要内容
临床试验/NCT00113178
NCT00113178已完成3 期

Clinical Study to Evaluate the Safety and Efficacy of the CryoCor™ Cardiac Cryoablation System for the Treatment of Cavo-Tricuspid Valve Isthmus-Dependent Atrial Flutter

Boston Scientific Corporation0 个研究点目标入组 160 人开始时间: 2004年1月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
160
主要终点
Acute efficacy

研究概览

简要总结

The purpose of this study is to evaluate the safety and efficacy of right atrial intra-cardiac lesions created by transvenous catheter cryoablation in patients with atrial flutter.

详细描述

Catheter ablation of arrhythmias has become an accepted alternative to pharmacologic therapy. Cryoablation is a newer alternative to radiofrequency ablations. This study expands the prior pilot experience with the CryoCor™ Cardiac Cryoablation System to a larger cohort of patients with atrial flutter.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Symptomatic atrial flutter

排除标准

  • Prior ablation
  • Contraindication to intervention
  • Poor general health

结局指标

主要结局

Acute efficacy

Acute safety

次要结局

  • Long-term efficacy
  • Long-term safety

研究者

申办方类型
Industry

相似试验